These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4316242)

  • 1. Effect of polycations on growth and dissemination of the encephalomyocarditis virus in mice.
    Craighead JE
    J Virol; 1967 Oct; 1(5):988-95. PubMed ID: 4316242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrasting effects of polycations on plaquing efficiency of encephalomyocarditis virus variants.
    Craighead JE; Layne CH
    J Virol; 1969 Jan; 3(1):45-51. PubMed ID: 4306302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycation effect on virulence of nonpathogenic r+ variant of the encephalomyocarditis virus.
    Craighead JE
    Nature; 1967 May; 214(5089):716-7. PubMed ID: 4292805
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement and inhibition by anionic polymers of plaque development by a variant of Mengo encephalomyelitis virus.
    Campbell JB; Colter JS
    Ann Med Exp Biol Fenn; 1966; 44(2):282-9. PubMed ID: 4290666
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of DEAE-dextran, polybrene, dextran and dextran sulphate on spontaneous leukaemia development in AKR mice and virus induced leukaemia in BALB-c mice.
    Ebbesen P
    Br J Cancer; 1974 Jul; 30(1):68-72. PubMed ID: 4413876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ammonium 5-tungsto-2-antimoniate on encephalomyocarditis and vesicular stomatitis virus infections in mice.
    Werner GH; Jasmin C; Chermann JC
    J Gen Virol; 1976 Apr; 31(1):59-64. PubMed ID: 177729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of infectivity of encephalomyocarditis virus RNA by amphotericin B methyl ester.
    Borden EC; Booth BW; McBain JA
    J Gen Virol; 1979 Feb; 42(2):297-303. PubMed ID: 217959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of interferon action: inhibition of viral messenger ribonucleic acid translation in L-cell extracts.
    Friedman RM; Metz DH; Esteban RM; Tovell DR; Ball LA; Kerr IM
    J Virol; 1972 Dec; 10(6):1184-98. PubMed ID: 4345494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of antiviral and cell-inhibitory activity in interferon preparations.
    Borecký L; Fuchsberger N; Hájnická V; Stancek D; Zemla J
    Acta Virol; 1972 Jul; 16(4):356-8. PubMed ID: 4403180
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection.
    Gresser I; Tovey MG; Bandu ME; Maury C; Brouty-Boyé D
    J Exp Med; 1976 Nov; 144(5):1305-15. PubMed ID: 186554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differing attachment of diabetogenic and nondiabetogenic variants of encephalomyocarditis virus to beta-cells.
    Kaptur PE; Thomas DC; Giron DJ
    Diabetes; 1989 Sep; 38(9):1103-8. PubMed ID: 2475377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two amino acids, Phe 16 and Ala 776, on the polyprotein are most likely to be responsible for the diabetogenicity of encephalomyocarditis virus.
    Bae YS; Eun HM; Pon RT; Giron D; Yoon JW
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():639-45. PubMed ID: 1690262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encephalomyocarditis virus multiplication in the presence of pyronine.
    Semmel M; Huppert J
    J Gen Virol; 1970 Jun; 7(3):187-202. PubMed ID: 4318433
    [No Abstract]   [Full Text] [Related]  

  • 14. A genetically determined host factor controlling susceptibility to encephalomyocarditis virus-induced diabetes in mice.
    Kang Y; Yoon JW
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1207-13. PubMed ID: 8389806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of plating of human T cell leukemia virus type I and syncytium-inducing types of human immunodeficiency virus type 1 by polycations.
    Haraguchi Y; Takeuchi Y; Hoshino H
    AIDS Res Hum Retroviruses; 1997 Nov; 13(17):1517-23. PubMed ID: 9390751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-induced diabetes mellitus. XVIII. Inhibition by a nondiabetogenic variant of encephalomyocarditis virus.
    Yoon JW; McClintock PR; Onodera T; Notkins AL
    J Exp Med; 1980 Oct; 152(4):878-92. PubMed ID: 6252275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-inducing characteristics of MM virus.
    Giron DJ; Allen PT; Pindak FF; Schmidt JP
    Appl Microbiol; 1971 Mar; 21(3):387-93. PubMed ID: 4324191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of blood clearance rates on interferon production and virulence of Mengo virus plaque mutants in mice.
    Campbell JB; Buera JG; Tobias FM
    Can J Microbiol; 1970 Sep; 16(9):821-6. PubMed ID: 4319089
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of the protective effect against Mengo virus infection in mice of interferons induced by polyI:C and Mengo virus.
    Campbell JB; Buera JG
    Can J Microbiol; 1971 Dec; 17(12):1525-32. PubMed ID: 4333910
    [No Abstract]   [Full Text] [Related]  

  • 20. EMC virus infection in baboons as a model for studies on antiviral substances.
    Levin R; Yaari A; Gitelman J; Bino T; Rosenberg H; Kohn A
    Antiviral Res; 1986 Aug; 6(5):277-83. PubMed ID: 3021054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.